An Error Was Encountered

Error Number: 1054

Unknown column 'cache_on' in 'field list'

UPDATE `aff_pdf_cache` SET `cache` = 'a:10:{i:0;O:8:\"stdClass\":13:{s:2:\"id\";s:6:\"312994\";s:6:\"status\";s:8:\"verified\";s:11:\"author_name\";s:17:\"rnrmarketresearch\";s:9:\"author_id\";s:6:\"116521\";s:14:\"author_website\";s:0:\"\";s:5:\"title\";s:111:\"Pathways to Efficient Drug Development Market in Modeling and Simulation Outcomes to Fuel Pipeline Productivity\";s:11:\"description\";s:596:\"RnR Market Research, the leading business intelligence provider, has released its latest research report, “Pathways to Efficient Drug Development – Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity”. The report examines the reasons why the pharmaceutical industry is looking for improvements in efficiency whilst acknowledging that pharmaceutical R&D remains a long and risky process. It looks in detail at precompetitive research and evaluates how the industry is pulling together to research solutions to problems that are common to all companies.\";s:5:\"thumb\";s:118:\"images/t/3130/pathways-to-efficient-drug-development-market-in-modeling-and-simulation-outcomes-to-fuel-pipeline-p.jpg\";s:6:\"thumb2\";s:119:\"images/t2/3130/pathways-to-efficient-drug-development-market-in-modeling-and-simulation-outcomes-to-fuel-pipeline-p.jpg\";s:9:\"permalink\";s:100:\"pathways-to-efficient-drug-development-market-in-modeling-and-simulation-outcomes-to-fuel-pipeline-p\";s:5:\"pages\";s:1:\"4\";s:6:\"rating\";s:1:\"0\";s:5:\"voter\";s:1:\"0\";}i:1;O:8:\"stdClass\":13:{s:2:\"id\";s:6:\"104556\";s:6:\"status\";s:8:\"verified\";s:11:\"author_name\";s:6:\"birgit\";s:9:\"author_id\";s:1:\"0\";s:14:\"author_website\";s:0:\"\";s:5:\"title\";s:56:\"Critical Thinking and Breaking Down The Barriers To Exit\";s:11:\"description\";s:57:\"Critical Thinking and Breaking Down The Barriers To Exit \";s:5:\"thumb\";s:101:\"data/thumb/Critical-Thinking-and-Breaking-Down-The-Barriers-To-Exit-Presentation-Transcript-23261.jpg\";s:6:\"thumb2\";s:102:\"data/thumb2/Critical-Thinking-and-Breaking-Down-The-Barriers-To-Exit-Presentation-Transcript-23261.jpg\";s:9:\"permalink\";s:56:\"critical-thinking-and-breaking-down-the-barriers-to-exit\";s:5:\"pages\";s:1:\"4\";s:6:\"rating\";s:1:\"0\";s:5:\"voter\";s:1:\"0\";}i:2;O:8:\"stdClass\":13:{s:2:\"id\";s:5:\"10851\";s:6:\"status\";s:8:\"verified\";s:11:\"author_name\";s:7:\"samanta\";s:9:\"author_id\";s:4:\"1916\";s:14:\"author_website\";s:0:\"\";s:5:\"title\";s:94:\"Barriers to Entry Analysis of Broadband Multiple Platforms: Comparing the U.S. and South Korea\";s:11:\"description\";s:2149:\"This paper compares barriers to entry in the broadband markets between the U.S. and South Korea. First, it explores economic conceptions of barriers to entry from the economics literature. Second, it speculates on how the conception of barriers to entry has been dealt with in the telecommunications industry. It clarifies the various industrial factors that could prevent, or make it difficult, to successfully enter the residential telecommunications market. Third, it introduces an analytical framework that can be adopted for evaluating the barriers to entry. Fourth, employing that framework, it examines the broadband markets in the U.S. and in South Korea, focusing on barriers to entry in multiple broadband access platforms. Both the U.S. and South Korea have shown greater barriers to entry in wireline broadband markets such as cable modem and DSL compared to wireless broadband when it comes to a facilities-based entry. South Korea has offered more opportunity to non-dominant ISPs as new entrants and thus, has been able to facilitate more vibrant competition nationwide. This paper concludes with an analysis of the barriers to entry for alternative broadband access platforms in residential high speed Internet services, more specifically, wireless access technologies, including other economic and policy factors in the US and South Korea. The sluggish progress of intermodal and intramodal market competition explains a part of the sluggish demand in the residential high speed Internet access market in the U.S., while the South Korean market was able to grow rapidly due to fierce competition in the market, mostly facilitated by the Korean government\'s open access rule and policy choices more favorable to new entrants rather than to the incumbents. Furthermore, near monopoly control of the residential communications infrastructure by cable operators and telephone companies manifests itself as relatively high pricing and lower quality in the U.S. The more favorable terms from which the dominant providers have benefited, and government\'s deregulation, may limit business opportunities for other Internet service providers.\";s:5:\"thumb\";s:109:\"images/t/109/barriers-to-entry-analysis-of-broadband-multiple-platforms-comparing-the-u-s-and-south-korea.jpg\";s:6:\"thumb2\";s:110:\"images/t2/109/barriers-to-entry-analysis-of-broadband-multiple-platforms-comparing-the-u-s-and-south-korea.jpg\";s:9:\"permalink\";s:92:\"barriers-to-entry-analysis-of-broadband-multiple-platforms-comparing-the-u-s-and-south-korea\";s:5:\"pages\";s:2:\"39\";s:6:\"rating\";s:1:\"0\";s:5:\"voter\";s:1:\"0\";}i:3;O:8:\"stdClass\":13:{s:2:\"id\";s:6:\"292841\";s:6:\"status\";s:8:\"verified\";s:11:\"author_name\";s:9:\"benturner\";s:9:\"author_id\";s:5:\"82024\";s:14:\"author_website\";s:0:\"\";s:5:\"title\";s:80:\"Accelerating Drugs, Drug Development, pharmaceutical companies, final medication\";s:11:\"description\";s:319:\"The report highlights major strategies adopted by pharmaceutical companies to accelerate drug development. The adoption of the latest technologies in lead generation, preclinical stages, and the use of adaptive designs in late phase studies are regarded as tools to accelerate drugs through these stages of development.\";s:5:\"thumb\";s:95:\"images/t/2929/accelerating-drugs-drug-development-pharmaceutical-companies-final-medication.jpg\";s:6:\"thumb2\";s:96:\"images/t2/2929/accelerating-drugs-drug-development-pharmaceutical-companies-final-medication.jpg\";s:9:\"permalink\";s:77:\"accelerating-drugs-drug-development-pharmaceutical-companies-final-medication\";s:5:\"pages\";s:1:\"2\";s:6:\"rating\";s:1:\"0\";s:5:\"voter\";s:1:\"0\";}i:4;O:8:\"stdClass\":13:{s:2:\"id\";s:5:\"41179\";s:6:\"status\";s:8:\"verified\";s:11:\"author_name\";s:5:\"heidi\";s:9:\"author_id\";s:1:\"0\";s:14:\"author_website\";s:0:\"\";s:5:\"title\";s:68:\"How a major multinational is working to overcome the barriers to ...\";s:11:\"description\";s:1175:\"Despite the growing use of international assign- mentsandthehigh cost of expatriates, few global firms have found the key to gauging the success of their mobility program, especially their expatriate return on investment (ROI). The author reports on one global firm that has made great strides towardsa practical ROItool by targeting the fundamental sys- temsandprocesses needed to manage international assignments. The author also makes the case that an assignment\'spurpose, relative to business and/or organizational strategies, determines the types of inputs and outcomes to measure; and that ROI determinationsfor expatriates must include intangible and long-term benefits and costs. Given the rapid rise in the internationalization of markets, competition, and technology, expatriates—and in particular long-term expatriates—can provide much of the value-creation opportunities global firms are seeking. But as the number of assignments increases, along with their annual cost—by some estimates, two-to-four times the individual\'sbasesalary—the need to assure such assignments are being effectively utilized is fast becoming a strategic issue for many companies.\";s:5:\"thumb\";s:81:\"images/t/412/how-a-major-multinational-is-working-to-overcome-the-barriers-to.jpg\";s:6:\"thumb2\";s:82:\"images/t2/412/how-a-major-multinational-is-working-to-overcome-the-barriers-to.jpg\";s:9:\"permalink\";s:64:\"how-a-major-multinational-is-working-to-overcome-the-barriers-to\";s:5:\"pages\";s:2:\"10\";s:6:\"rating\";s:1:\"0\";s:5:\"voter\";s:1:\"0\";}i:5;O:8:\"stdClass\":13:{s:2:\"id\";s:5:\"10853\";s:6:\"status\";s:8:\"verified\";s:11:\"author_name\";s:7:\"samanta\";s:9:\"author_id\";s:4:\"1916\";s:14:\"author_website\";s:0:\"\";s:5:\"title\";s:56:\"Barriers to entry and the effect on future profitability\";s:11:\"description\";s:1496:\"Economic theory suggests that firms can erect barriers to entry to impede the normalization of risk-adjusted returns by preventing firms from entering and exiting markets. Thus, barriers to entry directly impact a firm\'s future profitability as well as the assumptions incorporated into forecasting and valuation models. This paper utilizes ex-post realizations of performance, adjusted by estimates of operational risk, to establish which expenditures of resources and effort are effective at protecting profits; suggesting firms have established real barriers against potential and existing competitors. We demonstrate that the inclusion of barrier to entry information in future profitability models increases explanatory power by 27 percent. There are several successful barrier variables that generalize across the entire sample including proxies for power over suppliers and the ability of a firm to credibly signal expected retaliation. Sorting on these barriers results in a three percent premium in risk-adjusted return on net operating assets (RNOA) both within the economy and within the industry. This is economically significant given that the mean risk-adjusted RNOA for the sample over a 30 year period is 3.1 percent. The evidence suggests that traditional variables used to capture barriers to entry such as proxies for economies of scale, capital requirements, product differentiation, and innovation do not result in persistent economic rents for the majority of firms.\";s:5:\"thumb\";s:73:\"images/t/109/barriers-to-entry-and-the-effect-on-future-profitability.jpg\";s:6:\"thumb2\";s:74:\"images/t2/109/barriers-to-entry-and-the-effect-on-future-profitability.jpg\";s:9:\"permalink\";s:56:\"barriers-to-entry-and-the-effect-on-future-profitability\";s:5:\"pages\";s:2:\"52\";s:6:\"rating\";s:1:\"0\";s:5:\"voter\";s:1:\"0\";}i:6;O:8:\"stdClass\":13:{s:2:\"id\";s:6:\"163988\";s:6:\"status\";s:8:\"verified\";s:11:\"author_name\";s:11:\"globalpanel\";s:9:\"author_id\";s:5:\"36644\";s:14:\"author_website\";s:0:\"\";s:5:\"title\";s:50:\"Portfolio Optimization for Global Drug Development\";s:11:\"description\";s:463:\"The goal is to meet strategic objectives selecting the \"best\" portfolio\nof internal and external drug development programs for funding and\nbalance company resources including money, manpower and\nmanufacturing capacity. Projects could be interdependent, have\nmultiple development scenarios, and are subject to multiple business\nrules specific for the company environment. Value of each project\ndepends on multiple factors, and could be quantitative or qualitative.\";s:5:\"thumb\";s:68:\"images/t/1640/portfolio-optimization-for-global-drug-development.jpg\";s:6:\"thumb2\";s:69:\"images/t2/1640/portfolio-optimization-for-global-drug-development.jpg\";s:9:\"permalink\";s:50:\"portfolio-optimization-for-global-drug-development\";s:5:\"pages\";s:1:\"2\";s:6:\"rating\";s:1:\"0\";s:5:\"voter\";s:1:\"0\";}i:7;O:8:\"stdClass\":13:{s:2:\"id\";s:5:\"10852\";s:6:\"status\";s:8:\"verified\";s:11:\"author_name\";s:7:\"samanta\";s:9:\"author_id\";s:4:\"1916\";s:14:\"author_website\";s:0:\"\";s:5:\"title\";s:35:\"Barriers to Entry and Profitability\";s:11:\"description\";s:755:\"Barriers to entry are regarded as major impediments to the working of markets. Entry must not necessarily actually take place - the perceived threat of entry may encourage incumbent firms to behave as if they are in a competitive market, even if they are not. We present empirical evidence on effects of perceived threat of entry on profitability. Using information from managers about how they assess the existence of entry barriers a strong impact of these assessments on profitability is confirmed. The number and the relative size of competitors also exert considerable effects. We find no statistically significant relation between the perceived threat of entry and the actual number of firms if the size of the relevant market is taken into account.\";s:5:\"thumb\";s:52:\"images/t/109/barriers-to-entry-and-profitability.jpg\";s:6:\"thumb2\";s:53:\"images/t2/109/barriers-to-entry-and-profitability.jpg\";s:9:\"permalink\";s:35:\"barriers-to-entry-and-profitability\";s:5:\"pages\";s:2:\"24\";s:6:\"rating\";s:1:\"0\";s:5:\"voter\";s:1:\"0\";}i:8;O:8:\"stdClass\":13:{s:2:\"id\";s:5:\"10854\";s:6:\"status\";s:8:\"verified\";s:11:\"author_name\";s:7:\"samanta\";s:9:\"author_id\";s:4:\"1916\";s:14:\"author_website\";s:0:\"\";s:5:\"title\";s:71:\"Dynamic Analysis of Barriers to Entry as a Task for an Intelligent Tool\";s:11:\"description\";s:659:\"The paper addresses the problem of dynamic analysis of barriers to entry in a chosen market. The role and importance of such analysis in enterprise strategy is explained. As a solution to the problem, the use of an intelligent tool is proposed. The tasks that such a tool should be able to perform and the expectations connected with such a tool are pointed out. Next, an architecture of an intelligent tool is proposed. The main components of the tool are presented and discussed. Problems to be solved during construction process of the tool are also pointed out. The paper also shows direction for future research concerning dynamic analysis of barriers.\";s:5:\"thumb\";s:88:\"images/t/109/dynamic-analysis-of-barriers-to-entry-as-a-task-for-an-intelligent-tool.jpg\";s:6:\"thumb2\";s:89:\"images/t2/109/dynamic-analysis-of-barriers-to-entry-as-a-task-for-an-intelligent-tool.jpg\";s:9:\"permalink\";s:71:\"dynamic-analysis-of-barriers-to-entry-as-a-task-for-an-intelligent-tool\";s:5:\"pages\";s:2:\"11\";s:6:\"rating\";s:1:\"0\";s:5:\"voter\";s:1:\"0\";}i:9;O:8:\"stdClass\":13:{s:2:\"id\";s:5:\"10855\";s:6:\"status\";s:8:\"verified\";s:11:\"author_name\";s:7:\"samanta\";s:9:\"author_id\";s:4:\"1916\";s:14:\"author_website\";s:0:\"\";s:5:\"title\";s:99:\"Barriers to Entry of a Vertically Integrated Health Insurer: An Analysis of Welfare and Entry Costs\";s:11:\"description\";s:1616:\"This paper investigates the welfare e¤ectsofmarket entry by vertically integrated health insurers and the reasons why recent expansion attempts by these insurers have failed. Integrated health plans o¤erbothadvantages and disadvantages compared to their competitors. They limit their provider networks signi…cantlybuto¤er high-quality preventive care and broad coverage in exchange for the reduction in consumer choice. I use an econometric model of consumer demand for hospitals and insurers to simulate the welfare e¤ectsofentryofan integrated plan into 28 newmarkets. The analysis takes into account the e¤ectofintegration on the number of hospitals and physicians, the technologies available, the quality of preventive care and the premiums charged by all plans in the market. The baseline results, with no entry barriers included, imply that total social surplus would increase by over$34 billion per year if an integrated plan entered each of the 28 markets in the data. I then use the simulation model to investigate the magnitudes of several potential barriers to entry. The results indicate that three issues are particularly important. Integrated plans cannot attract enough enrollees to support their provider networks unless they can signi…cantlyexceed their competitors\'quality levels and convince consumers of this bene…t. Both tasks have become more di¢cultas competition has increased with the growth of managed care. Regulatory costs caused by Certi…cate of Need laws, which restrict plans\'ability to build new facilities, can also be important.\";s:5:\"thumb\";s:115:\"images/t/109/barriers-to-entry-of-a-vertically-integrated-health-insurer-an-analysis-of-welfare-and-entry-costs.jpg\";s:6:\"thumb2\";s:116:\"images/t2/109/barriers-to-entry-of-a-vertically-integrated-health-insurer-an-analysis-of-welfare-and-entry-costs.jpg\";s:9:\"permalink\";s:98:\"barriers-to-entry-of-a-vertically-integrated-health-insurer-an-analysis-of-welfare-and-entry-costs\";s:5:\"pages\";s:2:\"52\";s:6:\"rating\";s:1:\"0\";s:5:\"voter\";s:1:\"0\";}}', `cache_on` = '2015-02-28 14:18:10' WHERE `aff_id` = '1377283'